Re: TSX Review
|
4
|
Resverlogix Corp.
|
Mar 14, 2018 02:27AM
|
Re: trying to making sense
|
2
|
Resverlogix Corp.
|
Mar 09, 2022 10:25PM
|
Re: trying to making sense
|
3
|
Resverlogix Corp.
|
Mar 09, 2022 02:18PM
|
Re: Trying to get my head around this
|
4
|
Zenith Epigenetics
|
May 02, 2018 03:06AM
|
Re: Trying to get my head around this
|
3
|
Zenith Epigenetics
|
May 03, 2018 03:35AM
|
Re: Trodelvy - development history and valuations along the way
|
|
Zenith Epigenetics
|
Jul 04, 2023 02:35PM
|
Re: Travel Point of Interest
|
2
|
Resverlogix Corp.
|
Dec 22, 2017 02:52PM
|
Re: Transfer of ZEN from RBC DI to TFSA
|
4
|
Zenith Epigenetics
|
May 12, 2019 06:48PM
|
Re: Trading this stock
|
5
|
Resverlogix Corp.
|
Jul 27, 2018 12:39PM
|
Re: Trading this stock
|
1
|
Resverlogix Corp.
|
Jul 28, 2018 01:16AM
|
Re: Trading indicates bad news coming
|
8
|
Resverlogix Corp.
|
Jun 20, 2019 03:28PM
|
Re: Trading indicates bad news coming
|
3
|
Resverlogix Corp.
|
Jun 20, 2019 04:26PM
|
Re: Toxicity
|
3
|
Zenith Epigenetics
|
Nov 02, 2022 09:26PM
|
Re: Toxicity
|
4
|
Zenith Epigenetics
|
Nov 03, 2022 04:08PM
|
Re: Toxicity
|
5
|
Zenith Epigenetics
|
Mar 24, 2023 02:30PM
|
Re: Total Shares Outstanding 10/15/20
|
2
|
Resverlogix Corp.
|
Oct 16, 2020 05:21PM
|
Re: Total (MACE) Events?
|
4
|
Resverlogix Corp.
|
Jun 18, 2017 06:54PM
|
Re: toronto appliance repair
|
1
|
Zenith Epigenetics
|
Nov 27, 2022 02:07PM
|
Re: Top-Line, Primary Outcomes, Secondary Outcomes, Exploratory Outcomes, and Alzheimer's/Cognitio...
|
1
|
Resverlogix Corp.
|
Jul 13, 2018 01:50AM
|
Re: Top-line vs. Full Detailed Clinical Trial Results
|
2
|
Resverlogix Corp.
|
Dec 07, 2018 05:13PM
|